Apelin effects on lipopolysaccharide-increased pulmonary permeability in rats

Area of Science:

• Pharmacology
• Pulmonary Medicine
• Inflammation Research

Background:

• Lipopolysaccharide (LPS) induces significant lung vascular leak, a critical factor in inflammatory conditions.
• Endothelial dysfunction and inflammatory cell activation play key roles in LPS-induced lung injury.
• Therapeutic strategies targeting vascular permeability and inflammation are crucial for managing lung pathologies.

Purpose of the Study:

• To investigate the protective effects of apelin-13 (AP-13), sodium butyrate (BUT), and N-acetyl-L-cysteine (NAC) against LPS-induced lung vascular leak in a rat model.
• To explore the potential mechanisms of action and synergistic interactions between these agents.

Main Methods:

• Rats were pretreated with AP-13, BUT, or NAC before intranasal LPS administration.
• Vascular leak was quantified by measuring Evans blue extravasation in lung tissue.
• Comparative analysis of individual and combined treatment effects was performed.

Main Results:

• AP-13, BUT, and NAC individually reduced LPS-induced lung vascular leak.
• No significant difference was observed between AP-13 and NAC treatments, suggesting shared mechanisms.
• Combined BUT and NAC treatments demonstrated synergistic effects, exceeding the efficacy of individual agents.
• AP-13's effects may involve modulation of endothelial layer functions.

Conclusions:

• AP-13, BUT, and NAC are effective in mitigating LPS-induced lung vascular leak.
• AP-13 and NAC likely share common mechanistic pathways, possibly involving NF-kB.
• The combination of BUT and NAC offers enhanced therapeutic potential due to additive or synergistic anti-inflammatory effects.